AI for healthcare & life sciences

Custom AI/ML solutions for healthcare & life sciences industry

Custom AI and ML for hospital systems, payers, pharma, and biotech. Clinical decision support, claim automation, drug repurposing, and trial feasibility — built for HIPAA and FDA scrutiny.
80–90%

Phase 1 success rate for AI-discovered molecules vs 40–65% traditional pipelines.

<5 min

Prior-auth letter drafting with LLMs — down from 30–60 minutes of clinician + staff time.

85%

Of first-time claim denials are preventable with pre-submission ML classifiers.

Achieve immediate, organization-wide results

Six measurable outcomes across underwriting, claims, and actuarial functions — deployed in months, not years.

Ambient Clinical Documentation

LLMs draft notes from the conversation in the exam room. Clinicians get hours back per day; coders get cleaner structured data.

Prior Authorization Automation

Auth letters drafted in under 5 minutes vs 30–60. Approval rates up 5–15% with payer-policy-aware drafting.

Medical Imaging Triage

FDA-cleared radiology AI for stroke CT, chest X-ray, ECG arrhythmia, and fundus. Plug into your PACS to prioritize the worklist and surface critical findings minutes faster.

Claims Denial Prevention

Pre-submission classifiers catch the 85% of denials that are preventable — before the claim leaves your billing system.

AI-Native Drug Discovery

Target ID through clinical candidate in 18 months at six-figure outlay — not 5–6 years and tens of millions.

Pharma R&D Research AI

RAG-grounded research-AI over PubMed + ClinicalTrials.gov + your private R&D corpus. Custom alternative to Elicit / Consensus / Scite for IP-sensitive pharma and biotech R&D.

Capabilities across the healthcare & life sciences value chain

Clinical Decision Support & Ambient Care

Claims & Revenue Cycle Automation

Drug Discovery & Trial Acceleration

Population Health & Payer Intelligence

From the playbook

How a regional health system cut prior-auth time 60% and recovered $1.8M annually

A 6-hospital regional system was processing 4,800 prior authorizations per month, with each one consuming 35–45 minutes of clinician + staff time. We built a prior-auth letter-drafting LLM trained on their approved-letter corpus plus payer-specific policy ingestion. Auth letters now take 6–8 minutes end-to-end with clinician review, denial rates dropped from 22% to 14%, and annual recovered staff time hit $1.8M. The same data pipeline now powers downstream denial-prevention classifiers that catch incomplete submissions before they leave the EHR.

See more case studies →

START TODAY

Speak with a healthcare AI expert

A 45-minute scoping call. We’ll come prepared with your appetite, your loss-cost benchmarks, and a directional read on which models move the needle on your line of business.

Ask us about

    Contact Us
    Need experts to collaborate with for your AI/ML journey? Drop us an email and we will get in touch

    Frequently asked questions

    How do you handle HIPAA and PHI in training data?
    All work happens in your environment or in a single-tenant cloud account you own under HIPAA Business Associate Agreement. PHI never leaves your perimeter for training; we use synthetic data, de-identified extracts, or differential privacy where the model architecture allows. Every project ships with a Privacy Impact Assessment and audit-ready data lineage documentation.
    Yes — we build to the FDA's Good Machine Learning Practice principles from day one. Models intended for SaMD submission ship with predetermined change control plans (PCCP), full validation packs against holdout cohorts, and the documentation needed for 510(k) or De Novo pathways.
    Both — depending on what you want to own. Most clients integrate directly with their Epic / Cerner / Meditech via FHIR + HL7 so models read live data and write decisions back to the EHR. For research-grade work (drug discovery, trial feasibility), we typically run alongside the EHR on a separate data lake. Either way, you own the integration code and the model artifacts.
    Yes for the underlying ML platform (feature store, model registry, monitoring, governance) — those are reusable across all three. The domain models differ: hospital ops models target clinical and operational outcomes, payer models target risk and claims, pharma models target target-discovery and trial feasibility. Most integrated delivery networks running their own plan run one shared platform with three model families on top.

    Explore AI/ML solutions for healthcare & life sciences

    Ready to talk healthcare AI?

    Start with a 45-minute strategy session. We come prepared with a directional read on your line of business and a scoped proposal.